An examination of liver echographies performed over an 11 year period in 2,335 female patients with pelvic gynaecology cancers revealed that the incidence of benign lesions (96 cases) was greater than the number of metastases discovered (79 cases). Regular hepatic echography in cancers of the uterus leads to a median survival of 4 months. Hepatic echography can be useful for the detection of benign lesions in cases of cancer of the uterus and for the detection of benign or malignant lesions in cases of cancer of the ovary. Routine post-therapeutic hepatic echography is only useful in cancer of the cervix. For cancer of the ovary, abdomino-pelvic computed tomography should be performed; liver tests are sufficient in cases of cancer of the endometrium.